340 related articles for article (PubMed ID: 23207774)
1. Metabotropic glutamate receptor 5 activation enhances tyrosine phosphorylation of the N-methyl-D-aspartate (NMDA) receptor and NMDA-induced cell death in hippocampal cultured neurons.
Takagi N; Besshoh S; Marunouchi T; Takeo S; Tanonaka K
Biol Pharm Bull; 2012; 35(12):2224-9. PubMed ID: 23207774
[TBL] [Abstract][Full Text] [Related]
2. Effects of metabotropic glutamate mGlu5 receptor antagonist on tyrosine phosphorylation of NMDA receptor subunits and cell death in the hippocampus after brain ischemia in rats.
Takagi N; Besshoh S; Marunouchi T; Takeo S; Tanonaka K
Neurosci Lett; 2012 Nov; 530(1):91-6. PubMed ID: 23022504
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.
Pisani A; Gubellini P; Bonsi P; Conquet F; Picconi B; Centonze D; Bernardi G; Calabresi P
Neuroscience; 2001; 106(3):579-87. PubMed ID: 11591458
[TBL] [Abstract][Full Text] [Related]
4. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons.
Heidinger V; Manzerra P; Wang XQ; Strasser U; Yu SP; Choi DW; Behrens MM
J Neurosci; 2002 Jul; 22(13):5452-61. PubMed ID: 12097497
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator.
Rosenbrock H; Kramer G; Hobson S; Koros E; Grundl M; Grauert M; Reymann KG; Schröder UH
Eur J Pharmacol; 2010 Aug; 639(1-3):40-6. PubMed ID: 20371241
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A₂A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation.
Sarantis K; Tsiamaki E; Kouvaros S; Papatheodoropoulos C; Angelatou F
J Neurochem; 2015 Nov; 135(4):714-26. PubMed ID: 26303340
[TBL] [Abstract][Full Text] [Related]
9. Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.
Guo W; Wei F; Zou S; Robbins MT; Sugiyo S; Ikeda T; Tu JC; Worley PF; Dubner R; Ren K
J Neurosci; 2004 Oct; 24(41):9161-73. PubMed ID: 15483135
[TBL] [Abstract][Full Text] [Related]
10. Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes.
Benquet P; Gee CE; Gerber U
J Neurosci; 2002 Nov; 22(22):9679-86. PubMed ID: 12427823
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects.
Tebano MT; Martire A; Rebola N; Pepponi R; Domenici MR; Grò MC; Schwarzschild MA; Chen JF; Cunha RA; Popoli P
J Neurochem; 2005 Nov; 95(4):1188-200. PubMed ID: 16271052
[TBL] [Abstract][Full Text] [Related]
13. mGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway.
Chen HH; Liao PF; Chan MH
J Biomed Sci; 2011 Feb; 18(1):19. PubMed ID: 21342491
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression.
Izumi Y; Zorumski CF
Neuropsychopharmacology; 2012 Feb; 37(3):609-17. PubMed ID: 21993209
[TBL] [Abstract][Full Text] [Related]
15. Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield.
Wu GM; Hou XY
Brain Res; 2010 Jul; 1343():186-93. PubMed ID: 20441772
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents.
Blaabjerg M; Fang L; Zimmer J; Baskys A
Exp Neurol; 2003 Oct; 183(2):573-80. PubMed ID: 14552898
[TBL] [Abstract][Full Text] [Related]
17. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor 1 activity generates persistent, N-methyl-D-aspartate receptor-dependent depression of hippocampal pyramidal cell excitability.
Clement JP; Randall AD; Brown JT
Eur J Neurosci; 2009 Jun; 29(12):2347-62. PubMed ID: 19490024
[TBL] [Abstract][Full Text] [Related]
19. Regulation of phosphorylation of NMDA receptor NR1 subunits in the rat neostriatum by group I metabotropic glutamate receptors in vivo.
Choe ES; Shin EH; Wang JQ
Neurosci Lett; 2006 Feb; 394(3):246-51. PubMed ID: 16300895
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
